Mechanism of selenium-induced inhibition of arsenic-enhanced UVR carcinogenesis in mice

Environmental Health Perspectives

Volumn 116, Issue 6, 2008, Pages 703-708

  Burns, Fredric J ^a   Rossman, Toby ^a   Vega, Katherine ^a   Uddin, Ahmed ^a   Vogt, Stefan ^b   Lai, Barry ^b   Reeder, Richard J ^c  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ARGONNE NATIONAL LABORATORY   (United States)

^c STONY BROOK UNIVERSITY   (United States)

Author keywords

Arsenic; Cancer; Mouse; Prevention; Radiation; Selenium; Skin; Ultraviolet; UVR

Indexed keywords

ARSENIC; ORGANOSELENIUM DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; EPIDERMIS; HAIR FOLLICLE; LIVER CARCINOGENESIS; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; RADIATION ABSORPTION; RADIATION CARCINOGENESIS; RADIATION EXPOSURE; SKIN CARCINOGENESIS; SKIN EPITHELIUM; TISSUE DISTRIBUTION; ULTRAVIOLET RADIATION; X RAY FLUORESCENCE;

ANIMALS; ANTINEOPLASTIC AGENTS; ARSENIC; MICE; MICE, HAIRLESS; NEOPLASMS, RADIATION-INDUCED; ORGANOSELENIUM COMPOUNDS; SELENIUM; SKIN NEOPLASMS; SPECTROMETRY, X-RAY EMISSION; ULTRAVIOLET RAYS;

MUS;

EID: 46749137543     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.10978     Document Type: Article

References (36)

1. Burk R, Hill K, Motley A. 2003. Selenoprotein metabolism and function: evidence for more than one function for selenoprotein P. J Nutr 133:1517S-1520S.
2. Burns FJ, Uddin AN, Wu F, Nadas A, Rossman TG. 2004. Arsenic-induced enhancement of ultraviolet radiation carcinogenesis in mouse skin: a dose-response study. Environ Health Perspect 112:599-603.
3. Choiu H-Y, Hsueh Y-M, Liaw KF, Horng SF, Chiang M-H, Pu YS, et al. 1995. Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan. Cancer Res 55:1296-1300.
4. Chu FF, Esworthy RS, Chu PG, Longmate JA, Huycke MM, Wilczynski S, et al. 2004. Bacteria-induced intestinal cancer in mice with disrupted Gpx1 and Gpx2 genes. Cancer Res 64:962-968.
5. Das RK, Ghosh S, Sengupta A, Das S, Bhattacharya S. 2004. Inhibition of DMBA/croton oil-induced two-stage mouse skin carcinogenesis by diphenylmethyl selenocyanate. Eur J Cancer Prev 13(5):411-417.
6. Gailer J, George GN, Harris HH, Pickering IJ, Prince RC, Somogyi A, et al. 2002a. Synthesis, purification, and structural characterization of the dimethyidiselenoarsinate anion. Inorg Chem 41(21):5426-5432.
7. Gailer J, George GN, Pickering IJ, Prince RC, Ringwald SC, Pemberton JE, et al. 2000. A metabolic link between arsenite and selenite: the seleno-bis(S-glutathionyl) arsinium ion. J Am Chem Soc 122:4637-4639.
8. 2AsSe]-after intravenous injection of rabbits with arsenite and selenate. Chem Res Toxicol 15(11):1466-1471.
9. Gallegos A, Berggren M, Gasdaska JR, Powis G. 1997. Mechanisms of the regulation of thloredoxin reductase activity in cancer cells by the chemopreventative agent selenium. Cancer Res 57(21):4965-4970.
10. Gentry PR, Covington TR, Mann S, Shipp AM, Yager JW, Clewell HJ III. 2004. Physiologically based pharmacokinetic modeling of arsenic in the mouse. J Toxicol Environ Health A 67(1):43-71.
11. Goering P, Aposhian H, Mass M, Cebrian M, Beck B, Waalkes M. 1999. The enigma of arsenic carcinogenesis: role of metabolism. Toxicol Sci 49(1):5-14.
12. Hatfield DL, Gladyshev VN. 2002. How selenium has altered our understanding of the genetic code. Mol Cell Biol 22:3565-3576.
13. Hattori Y, Nishigori C, Tanaka T, Uchida K, Nikaido O, Osawa T, et al. 1996. 8-Hydroxy-2′-deoxyguanosine is increased in epidermal cells of hairless mice after chronic ultraviolet B exposure J Invest Dermatol 107(5):733-737.
14. Haugen A, Kelley R, Collins J, Tucker C, Deng C, Afshari C, et al. 2004. Integrating phenotypic and expression profiles to map arsenic-response networks. Genome Blol 5(12):95; doi:10.1186/gb-2004-5-12-r95 [Online 29 November 2004].
15. Hei T, Liu S, Waldren C. 1998. Mutagenicity of arsenic in mammalian cells: role of reactive oxygen species. Proc Natl Acad Sci USA 95(14):8103-8107.
16. Hertz-Picciotto I, Smith A, Holtzman D, Lipsett M. Alexeeff G. 1992. Synergism between occupational arsenic exposure and smoking in the induction of lung cancer. Epidemiology 3:23-31.
17. Karbownik M, Lewinski A, Reiter RJ. 2001. Anticarcinogenic actions of melatonin which involve antioxidative processes: comparison with other antioxidants. Int J Biochem Cell Biol 33(8):735-753.
18. Kim P, Zamora R, Petrosko P, Billiar T. 2001. The regulatory role of nitric oxide in apoptosis. Int Immunopharmacol 1(8):1421-1441.
19. Lewin SW, Arthur JR, Riemersma RA, Nicol F, Walker SW, Millar EM, et al. 2002. Selenium supplementation acting through the induction of thioredoxin reductase and glutathione peroxidase protects the human endothelial cell. Biochim Biophys Acta 1593:85-92.
20. Manley S, George G, Pickering I, Glass R, Prenner E, Yamdagni R, et al. 2006. The selano bis(S-glutathionyl) arsinium ion is assembled in erythrocyte lysate. Chem Res Toxicol 19(4):601-607.
21. Melnikova VO, Ananthaswamy HN. 2005. Cellular and molecular events leading to the development of skin cancer. Mutation Res 571(1-2):91-106.
22. Miyazaki K, Watanabe C, Mori K, Yoshida K, Ohtsuka R. 2005. The effects of gestational arsenic exposure and dietary selenium deficiency on selenium and selenoenzymes in maternal and fetal tissues in mice. Toxicology 208(3):357-365.
23. National Research Council. 1999. Risk Assessment of Arsenic in Drinking Water: Subcommittee on Arsenic in Drinking Water. Washington, DC:National Academy Press.
24. Nordenson I, Beckman L. 1991. Is the genotoxic effect of arsenic mediated by oxygen free radicals? Hum Hered 41(1):71-73.
25. Ray G, Husain SA. 2002. Oxidants, antioxidants and carcinogenesis. Indian J Exp Biol 40(11):1213-1232.
26. Rossman TG, Uddin AN, Burns FJ. 2004. Evidence that arsenite acts as a cocarcinogen in skin cancer. Toxicol Appl Pharmacol 198(3):394-404.
27. Rossman TG, Uddin AN, Burns FJ, Bosland MC. 2001. Arsenite is a cocarcinogen with solar ultraviolet radiation for mouse skin: an animal model for arsenic carcinogenesis. Toxicol Appl Pharmacol 176(1):64-71.
28. Rossman TG, Uddin AN, Burns FJ, Bosland MC. 2002. Arsenite cocarcinogenesis: an animal model derived from genetic toxicology studies. Environ Health Perspect 110(suppl 5):749-752.
29. Schomburg L, Schweizer U, Khrle J. 2004. Selenium and selenoproteins in mammals: extraordinary, essential, enigmatic. Cell Mol Life Sci 61:1988-1995.
30. Shi H, Shi X, Liu K. 2004. Oxidative mechanism of arsenic toxicity and carcinogenesis. Mol Cell Biochem 255:67-78.
31. Spyrou G, Bjornstedt M, Skog S, Holmgren A. 1996. Selenite and selenate inhibit human lymphocyte growth via different mechanisms. Cancer Res 56:4407-4412.
32. Uddin AN, Burns FJ, Rossman TG. 2005. Vitamin E and organoselenium prevent the cocarcinagenic activity of arsenite with solar UVR in mouse skin. Carcinogenesis 26(12):2179-2186.
33. Urbach F. 2002. The historical aspects of photocarcinogenesis. Front Biosci 7:85-90.
34. Vogt S. 2003. A set of software tools for analysis and visualization of 3D X-ray fluorescence data sets. J Phys IV 104:635-638.
35. Xuan X, Lubin J, Li J, Yang L, Luo A, Lan Y, et al. 1993. A cohort study in southern China of tin miners exposed to radon and radon decay products. Health Physics 64:120-131.
36. Yu H-S, Liao W-T, Chai C-Y. 2006. Arsenic carcinogenesis in the skin. J Biomed Sci 13(5):657-666.